Syneos Health Schedules Second Quarter 2018 Earnings Call for Thursday, August 2, 2018
July 12 2018 - 6:02PM
Syneos Health™ (Nasdaq:SYNH), the only fully integrated
biopharmaceutical solutions organization combining a CRO (Contract
Research Organization) and CCO (Contract Commercial Organization),
will release its second quarter 2018 financial results on Thursday,
August 2, 2018, prior to its earnings call at 8:00 a.m. ET.
Participants may access the conference call live via webcast on
the Investor Relations section of the Syneos
Health website at investor.syneoshealth.com. To
participate via telephone, please dial +1 877 930 8058
within the United States or +1 253 336 7551
outside the United States, approximately 15 minutes prior to
the scheduled start time. The conference ID for the call is
2556819.
A webcast replay will be available on the Investor Relations
section of the Syneos Health website
at investor.syneoshealth.com after 1:00
p.m. on August 2. In addition, an audio replay will be
available for one week following the call and will be accessible by
dialing +1 855 859 2056 within the United States or +1
404 537 3406 outside the United States. The replay ID is
2556819.
About Syneos HealthSyneos Health™ (Nasdaq:SYNH)
is the only fully integrated biopharmaceutical solutions
organization. Our company, including a Contract Research
Organization (CRO) and Contract Commercial Organization (CCO), is
purpose-built to accelerate customer performance to address modern
market realities. Created through the merger of two industry
leading companies – INC Research and inVentiv Health – we bring
together more than 21,000 clinical and commercial minds with the
ability to support customers in more than 110 countries. Together
we share insights, use the latest technologies and apply advanced
business practices to speed our customers’ delivery of important
therapies to patients. To learn more about how we are
shortening the distance from lab to life® visit
syneoshealth.com.
Investor Relations Contact:
Ronnie Speight
Vice President, Investor
Relations
+1 919 745 2745
investor.relations@syneoshealth.com
Press/Media Contact:Danielle DeForgeExecutive
Director, External Communications+1 781 425
2624danielle.deforge@syneoshealth.com
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024